Divi's Laboratories Ltd. (DIVISLAB)
BSE
Closed
Aug 26, 2026
Day's Range
8,703.8552 wk Range
5,637.50Profile - DIVISLAB - Divi's Laboratories Ltd.
Profile
Mic Code
XBOM
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
10.54K
Divi's Laboratories Ltd. is a pharmaceutical company based in India, known for its significant role in the global pharmaceuticals industry as a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Founded in 1990, the company focuses on the development and production of generic and custom synthesis APIs, which are crucial components in the manufacture of various medicines. Divi's Laboratories serves a diverse range of industries including generic pharmaceuticals, contact manufacturing of APIs, nutraceuticals, and custom synthesis of active ingredients for innovators. The company's strategic investments in state-of-the-art R&D facilities and production capabilities underscore its commitment to quality and compliance with international standards. It has a robust presence in international markets, with a substantial portion of its revenue generated from exports, highlighting its global market impact. Divi's plays a pivotal role in both the supply chain of pharmaceutical companies and in contributing to public health through the provision of essential drug components.
Profile Details
Type
Common Stock
Ceo
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
Address
Divi Towers
City
Hyderabad
Zip
500032
Country
India
Phone
91 40 6696 6300
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
